ReutersSanofi dengue vaccine promising but questions remainReutersPARIS (Reuters) – The first vaccine against dengue fever, from France’s Sanofi, provided moderate protection in a large clinical study, but questions remain as to how well it can help fight the world’s fastest-growing tropical disease. The late-stage trial involved …First dengue vaccine ‘shows promise’BBC NewsVaccine And Other Strategies May Soon Control Dengue FeverVoice of AmericaTrial: dengue shot offers some protectionSFGateBusinessweek -MarketWatch -The News Internationalall 30 news articles …Read Full Story
Sanofi dengue vaccine promising but questions remain - Reuters
Real Estate of Cebu
